Serum urocortin in preterm labor is it an effective biomarker?

Nancy Mohamed Ali Rund


Background: Preterm labor classically defined as delivery before completed 37 gestational weeks. Urocortin a biomarker that have raised recent research interest is a 40-amino acid neuropeptide related to the corticotrophin-releasing factor molecular family. Interestingly urocortin is produced by gestational tissue such as amnion and chorion predictability of preterm labor by biomarker assay could enhance management levels particularly in cases of preterm labor that are considered a frequent clinical scenario in obstetric practice. Aim of the study was to assess and evaluate the serum levels of urocortin predictability capacity in cases that develop preterm labor.

Methods: The current research clinical trial was conducted in a prospective way there was two research groups 60 study subjects had threatened preterm labor and 60 normal research study subjects that delivered at term. Comparative analysis was performed for urocortin assay conducted in both research groups in correlation to gathered clinical data obtained from both research groups.

Results: Receiver operating characteristic curve (ROC) between preterm and term delivery research groups as regards plasma urocortin level (pg/ml) as a predictor of pre term delivery showing that a cut-off point level >101.3 pg/ml in which statistical sensitivity=88.33%, statistical specificity=75%, positive predictive value=77.9, negative predictive value=86.5.

Conclusions: This research finding reveal that maternal serum urocortin is an effective biomarker in predictability of preterm labor; however future research studies should be multicentric in fashion putting in consideration the racial and ethnic differences besides the impact of BMI on maternal serum urocortin indices.


Biomarker, Myometrial contractility, Preterm labor, Urocortin, Uteroplacental perfusion

Full Text:



Kashanian M, Bahasadri S, Ghasemi A, Bathaee S. Value of serum urocortin concentration in the prediction of preterm birth. J Obstet Gynaecol Res. 2013;39(1):26-30.

Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345:760–5.

Platt MJ. Outcomes in preterm infants. Public Health. 2014;128:399-403.

Feldman K, Woolcott C, O’Connell C, Jangaard K. Neonatal outcomes in spontaneous versus obstetrically indicated late preterm births in a nova scotia population. J Obstet Gynaecol Can. 2012;34:1158-66.

World Health Organization: Born Too Soon: The Global Action Report on Preterm Birth. Geneva: WHO Press; 2012.

Moroz LA, Simhan HN. Rate of sonographic cervical shortening and biologic pathways of spontaneous preterm birth. Am J Obstet Gynecol. 2014;210:555.e1-5.

Pawelec M, Pałczyński B, Krzemieniewska J, Karmowski M, Koryś J, Lątkowski K, et al. Initiation of preterm labor. Adv Clin Exp Med. 2013;22:283-8.

Kageyama K, Teui K, Tamasawa N, Suda T. Regulation and roles of urocortins in the vascular system. Int J Endocrinol 2012; 2012:873723.

Karaer A, Celik E, Celik O, Simsek OY, Ozerol İH, Yılmaz E, Turkcuoglu I, Duz SA: Amniotic fluid urocortin-1 concentrations for the prediction of preterm delivery. J Obstet Gynaecol Res 2013;39:1236-41.

Brown H, Speechley K, Macnab J, Natale R, Campbell M: Biological determinants of spontaneous late preterm and early term birth: a retrospective cohort study. BJOG. 2015;122:491-9.

Florio P, Linton EA, Torricelli M, Faldini E, Reis FM, Imperatore A. Prediction of preterm delivery based on maternal plasma urocortin. J Clin Endocrinol Metab. 2007;92:4734-7.

Florio P, Torricelli M, Galleri L, De Falco G, Leucci E, Calonaci G. High fetal urocortin levels at term and preterm labor. J Clin Endocrinol Metab. 2005;90:5361-5.

Torricelli M, Ignacchiti E, Giovannelli A, Merola A, Scarpetti E, Calonaci G. Maternal plasma corticotropinreleasing factor and urocortin levels in post-term pregnancies. Eur J Endocrinol. 2006;154:281-5.